Fig. 7From: Weipiling decoction alleviates N-methyl-N-nitro-N′-nitrosoguanidine-induced gastric precancerous lesions via NF-κB signalling pathway inhibitionWPL moderately attenuates the weight loss and food intake (FI) reduction caused by MNNG. A and C show the body weight (BW) gain and food consumption tendencies. B and D show the decrease in BW and food consumed. Data are described as the means ± standard deviation (SD) from three separate experiments. ###P < 0.001 versus the control group. *P < 0.05, **P < 0.01, ***P < 0.01 versus the MNNG-treated groupBack to article page